From splice defect to therapeutic opportunity: Insights from PRPF31
Molecular Therapy · 2026-10 · 34 (10) · 5624-5626
DOI: 10.1016/j.ymthe.2026.08.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Frauke Coppieters. Beteiligte Einrichtung: Department of Biomolecular Medicine, Department of Pharmaceutics, Center for Medical Genetics Ghent, Ghent University, Ghent, Belgium. Electronic add…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Foundation Fighting Blindness Inc, Ghent University, Research Foundation Flanders.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biomolecular Medicine, Department of Pharmaceutics, Center for Medical Genetics Ghent, Ghent University, Ghent, Belgium. Electronic address: frauke.coppieters@ugent.be.
Förderung
- Foundation Fighting Blindness Inc
- Ghent University
- Research Foundation Flanders
Zitieren
APA
Coppieters, F. (2026). From splice defect to therapeutic opportunity: Insights from PRPF31. Molecular Therapy, 34(10), 5624-5626. https://doi.org/10.1016/j.ymthe.2026.08.031
Vancouver
Coppieters F. From splice defect to therapeutic opportunity: Insights from PRPF31. Molecular Therapy. 2026;34(10):5624-5626. doi:10.1016/j.ymthe.2026.08.031
BibTeX
@article{Coppieters2026,
author = {Coppieters, Frauke},
title = {From splice defect to therapeutic opportunity: Insights from PRPF31},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {10},
pages = {5624--5626},
doi = {10.1016/j.ymthe.2026.08.031}
}
EUVIMED